Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Mise à jour : Il y a 4 ans
Référence : NCT00433017

Femme et Homme

Extrait

This study will evaluate the effect of combination therapy with verteporfin photodynamic therapy and ranibizumab on visual acuity compared to ranibizumab monotherapy and the durability of response observed in patients with choroidal neovascularization secondary to age-related macular degeneration


Critère d'inclusion

  • Macular degeneration ,Choroidal Neovascularization


Liens